Sign in
4

Changes in Ownership

BIO-TECHNE Corp Filed Acc 0000914190-21-000195

Chief Financial Officer sold 10,000 shares at an average $456.67 ($4,566,663)

  • Chief Financial Officer acquired 10,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Hippel James · Chief Financial Officer

Table I: Non-derivative

14 lines
Date Transaction Shares Price Value Owned after D/I
2021-07-12 Exercise or conversion : show line 1 in the form +10,000 $106.59 $1,065,900 19,137 D
2021-07-12 Sale : show line 2 in the form −600 $451.07 $270,640 18,537 D
2021-07-12 Sale : show line 3 in the form −751 $451.95 $339,416 17,786 D
2021-07-12 Sale : show line 4 in the form −788 $453.21 $357,126 16,998 D
2021-07-12 Sale : show line 5 in the form −662 $454.15 $300,647 16,336 D
2021-07-12 Sale : show line 6 in the form −1,773 $455.57 $807,717 14,563 D
2021-07-12 Sale : show line 7 in the form −527 $456.41 $240,527 14,036 D
2021-07-12 Sale : show line 8 in the form −1,136 $457.79 $520,055 12,900 D
Open-market sales · 10,000 sh · avg $456.67 · $4,566,663

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2021-07-12 Exercise or conversion : show line 15 in the form Stock Options (Right to Buy) −10,000 20,000 D
Loading xslF345X03/edgar.xml…